DrugDashboards

Clonazepam

Clonazepam · CLONAZEPAM 1 mg/1 · Tablet · Oral · Clinical Solutions Wholesale, LLC

NDC 58118-0153-08 · 30 TABLET in 1 BLISTER PACK · ANDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 16729-0137-16) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.0688per unit
middle half $0.0460–$0.1468 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0688
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 3% · step therapy 0% · qty limit 78%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clonazepam (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA075468
TE code
AB
Approval date
Oct 6, 2000
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 72888-153-01)Mar 27, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 0093-0832-05)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 16729-136-00)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 16729-136-16)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 43547-406-10)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 43547-406-11)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 43547-406-50)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 59651-722-01)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 59651-722-99)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 72888-152-00)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 72888-152-01)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 72888-152-05)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, .5 mg (NDC 72888-152-30)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 0093-3212-01)Mar 10, 2023
    Other
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 0093-3212-05)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 16729-137-00)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 16729-137-16)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 43547-407-10)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months
  • In shortage now — Clonazepam, Tablet, 1 mg (NDC 43547-407-11)Mar 10, 2023
    month 42 — 3× the typical 14-month oral solid shortage · model puts 37% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clonazepam (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Advanced Rx Pharmacy of Tennessee, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCCLONAZEPAM 1 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCCLONAZEPAM 2 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedCLONAZEPAM 1 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedCLONAZEPAM 2 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCLONAZEPAM 2 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Clinical Solutions Wholesale, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Coupler LLCCLONAZEPAM 1 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.CLONAZEPAM 1 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.CLONAZEPAM 2 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPCLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPCLONAZEPAM 1 mg/1Jul 15, 2026Sep 3, 2026
Remedyrepack Inc.CLONAZEPAM 2 mg/1Jul 15, 2026Sep 3, 2026
Remedyrepack Inc.CLONAZEPAM .5 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdCLONAZEPAM .25 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdCLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx of Tennessee, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCCLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026
Clinical Solutions Wholesale, LLCCLONAZEPAM 1 mg/1Jul 15, 2026Sep 2, 2026
Clinical Solutions Wholesale, LLCCLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCCLONAZEPAM .5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCCLONAZEPAM 2 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clonazepam — NDC 58118-0153-08," retrieved September 3, 2026, https://drugdashboards.com/drug/58118015308.

Free to cite with attribution — see how the data is put together.